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1. Introduction 
It was shown recently that native az-macroglobulin 
(cQM), Af, 725 000 contains one reactive, labile thiol 
ester in each of its 4 identical subunits of Iw, 180 000, 
which is formed by a particular Glx-residue, whose 
y-carboxyl group is esterified to the sulfhydryl group 
of a cysteinyl residue [13. 
Complex formation with proteinases involves not 
only limited proteolysis in the ‘bait’ region but also 
the rapid cleavage of this thiol ester as evidenced by 
the concurrent appearance of the SH-groups (max. 
4 mol/mol azM) [ 11. Denaturation of CY,M or treat- 
ment with CH3NH2 also leads to cleavage of this thiol 
ester [I]. 
During ‘inactivation’ of the proteinase binding 
capacity with CHaNH2 the latter,is incorporated 
covalently to form a y-glutamyl methylamide [ 1,2] 
indicating that this site in ozM may be a site for cova- 
lent binding of proteinase. Complement component 
C3 also reacts covalently with CH3NH2 again leading 
to the formation of y-glutamyl methylamide f3-51. 
The recent demonstration that the a-chain of C3 
probably also contains a thiol ester [4,5] later shown 
[6] to involve the Glx-residue and the Cys-residue’in 
the sequence: 
-Gly-Cys-Gly~lu~lx-Asn-Met 
which is identical to the sequence around the 
CHaNHa-reactive Glx-residue of oZM [ 1,7,8] shows 
that cuzM and C3 are structurally and functionally 
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related, at least with regard to this particular state. 
Here, we show that the Cys-residue constituting 
one part of the thiol ester structure in aaM is iocated 
in an identical sequence to that found in C3 [6]. 
2. Materials and methods 
Human 02M was prepared from plasma s in [ 11. 
CHaNH2 - HCl was obtained from Sigma, St Louis, 
MO. Bovine ~-chymot~psin was from Wor~ngton, 
Freehold, NJ. Iodo[ I-r4C]acetamide (53 Ci/mol) was 
obtained from the Radiochemical Centre, Amersham, 
iodoacetic acid was from Merck, Darmstadt. Sephadex 
G-25, G-50 fine and DEAE-Sephacel were from 
Pharmacia, Uppsala. 
Following initial separation of peptides on 
Sephadex G-50 fine and DEAE-Sephacel peptides 
were finally purified by high-voltage paper electro- 
phoresis and by paper chromatography [9J. Samples 
for amino acid analysis were hydrolysed in 6 M HQ, 
0.1% (v/v) phenol for 20 h at 110°C in 6 X 60 mm 
test tubes sealed at <I Torr and the hydrolysates 
analysed on a Beckman 121 MB amino acid analyzer 
using the standard single column hydrolyzate pro- 
gram. Automated Edman degradation was performed 
in a Beckman 890C Sequencer using 0.25 M Quadrol 
[ lo] and polybrene [111.25% t~fluoroacetic acid 
was used for conversion (55”C, 30 min) [ 121. After 
drying in vacua the PTH derivatives were analysed 
and quantitated by HPLC using an ethanol based sol- 
vent system [131 on a Hewlett-Packard 1084B liquid 
chromatograph. 
3. Experimental 
az-Macroglobulin (450 mg, -0.62 ~01) dissolved 
in 40 ml 0.05 M Na-phosphate, 0.1 M NaCl, 5 mM 
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Na2-EDTA (pH 8.0) was treated with CHaNH* . HCI 
(final cont. 50 mM) for 90 min at room temperature 
in order to achieve complete cleavage of the thiol 
ester group [ 11. The thiol groups were then labelled 
with iodo [ 1 -r4C] acetamide by adding 100 PCi, incu- 
bating for 120 min then followed by a 10 min incu- 
bation with 10 mM unlabelled iodoacetamide. The 
mixture was separated on a column of Sephadex G-25 
(5 X 49 cm) in 0.1 M NH4HC0a (pH 8.3). More than 
95% of the “C-label co-eluted with the material 
appearing in the void volume. This fraction was freeze 
dried and redissolved in 40 ml 6 M guanidinium chlo- 
ride, 0.1 M Na-phosphate @H 8.0) reduced with 
dithiothreitol and alkylated with iodoacetic acid 
essentially as in [ 141. After desalting on the G-25 
column in 0.1 M NH4HC0a (PH 8.0) all of the 14C- 
label was associated with the protein peak. The 
reduced, alkylated crzM (in 180 ml) was digested with 
chymotrypsin at 37°C for 24 h. Chymotrypsin (7 mg) 
was added to initiate digestion followed by 7 mg after 
6 h. The digestion was terminated by’addition of 
10 mg phenylmethane sulfonyl fluoride in 1 ml etha- 
nol and the solution was finally freeze dried. 
The material was redissolved in 0.1 M NH4HC03 
(pH 8.3) and loaded on a column of G-50 fine (fig.1). 
The pool containing the bulk of the r4C-label was 
I 
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Fig.1. Separation of chymotryptic peptides from the [ l-r4C]- 
carboxyamidomethylated, dithiothreitol, reduced, carboxy- 
methylated oZM on a column of Sephadex G-50 tbre 
(5 X 42 cm) equilibrated and eluted with 0.1 M NH,HCO, 
(pH 8.3) at a flowrate of 60 ml/h. Fractions of 10 ml were 
collected. The column effluent was monitored by measuring 
the A 280, by determining the radioactivity on 25 ~1 aliquots 
from every second tube and fingerprinting [ 91. Due to the 
complexity of the digest the material in the trailing part of 
the 14C-labelled peak was not included in the material that 
was pooled (horizontal bar). 
Fig.2. Separation of r4C-labelled chymotryptic peptides from 
the G-50 pool (fig.1) on a column of DEAE-Sephacel 
(1.6 X 32 cm) equilibrated with 10 mM NH,HCO, (pH 8.3) 
and eluted at a flowrate of 30 ml/h with two linear gradients 
of NH,HCO,, namely from lo-200 mM (300 ml + 300 ml) 
and from 200-600 mM (340 ml + 340 ml). Finally the col- 
umn was eluted with 1 M NH,HCO, (100 ml) (not shown). 
The separation was monitored by measuring the A 230, by 
determining the radioactivity on 25 ~1 aliquots and by finger- 
printing. Two pools (1,2) were collected (horizontal bars). 
freeze dried, redissolved in 20 ml 10 mM NH4HC0, 
(pH 8.3) loaded on a column of DEAE-Sephacel 
which was eluated with gradients of NH4HC03 
(fig.2). Most of the r4C-label (-75% and -25%, 
respectively) appeared in two pools which were freeze 
dried and subjected to high-voltage paper electro- 
phoresis at pH 6.5 and pH 2.1 followed by paper 
chromatography. 
4. Results and discussion 
Due to the large number of chymotryptic peptides 
in pool 1 (fig.2) it was found necessary to purify the 
peptides in 3 different systems, namely electrophore- 
sis at pH 6.5 and pH 2.1 followed by paper chroma- 
tography in n-butanol-acetic acid-water-pyridine 
(15:3:10:2 by vol.). The yield of peptide material 
was consequently rather low. One strongly radio- 
active peptide was isolated almost pure in a yield of 
130 nmol(S.2%) with the composition CmCys 0.7, 
Asx 1.1, Glx 2.0, Gly 1.8, Met 0.8, CHaNH* 1.0. 
Another slightly longer variant (+ Val, Leu) was 
recovered in a yield of -150 nmol in mixture with 
other peptides. 
On the Beckman 121MB analyzer CHJNHZ was 
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eluted 0.2-0.3 min after histidine as noted [6]. Sub- 
jecting a 30 nmol sample to automated sequence 
determination gave the sequence: 
Gly-CmCys-Gly-Glu-Glu(NHCHa)-Asn-Met 
(16.4,4.2,15.1,22.3,20.6,15.9,5.6 nmol, respectively) 
The amount of “C-label released in each step of 
the sequence determ~ation was measured on ali- 
quots of the PTH-derivatives and was found only in 
steps 2 (27,3 X lo4 cpm) and 3 (1.7 X IO4 cpm), 
respectively. This shows that the thiol group which 
becomes available to labeihng after breaking the thiol 
ester by treating 02M with CHsNHa is in fact the 
SH-group of the Cys-residue located 3 steps before 
the CHsNH*-reactive Glx-residue in the sequence of 
CQM (fig.3). 
Thus, not only the CHsNH,-reactive Gix-residue 
[ 1,281 but also the Cys-residue involved in the thiol 
ester bond between Cys and Glx in native azM [ 1 ] 
are part of a heptapeptide sequence in azM [ 1,2,8] 
identical to the heptapeptide sequence of complement 
component C3 [6] which contains the thiol ester 
bond between Cys and Glx in the C3 o-chain [6]. 
The PTH-derivative of y-glutamyl methylamide 
from step 5 of the chymotryptic peptide eluted 
-1.35 min after PTH-Gly on HPLC using our ethanol- 
based solvent system [ 131. When subjected to back 
hydrolysis [ 151 this derivative gave rise to two peaks 
on the amino acid analyzer corresponding to glutamic 
acid and methylamine. Furthermore, when the CNBr- 
fragment :
Pro-Tyr-Cay-Cys-Gly-Glu-Glu(NHCH,)-Asn-Hse 
isolated from azM that had been treated with 
14CHsNHz was subjected to sequence determination 
the only radioactive PTH-derivative found was 
obtained in step 7 and eluted in the HPLC system in 
the same position as the derivative from the chymo- 
tryptic peptide. 
Fig.3 shows a comparison between the sequences 
around the reactive thiol ester sites in olzM and 
in complement component C3. Clearly the two 
sequences are highly homologous which leads one to 
expect that larger parts of 02M and of the &chain of 
C3 will turn out to be homologous. 
Since a,M is a tetramer it is not clear whether its 
thiol ester groups form inter- or intra-chain bridges. 
Because of the homology with C3 and because C3 
contains only 1 a-chain/molecule it seems a reason- 
able prediction that the 4 thiol ester bonds in azM 
form intra-chain bridges. 
Of the estimated 1450 residues in each subunit of 
asM -1383 residues have now been placed in 3 long 
stretches of unique sequence (L. S.-J., T. M. Stepanik, 
D. M. Rider, P. B. Lonblad, T. E. P., S. M., unpub- 
lished), namely the N-terminal segment (440 resi- 
dues), the segment containing the ‘bait’ region (298 
residues) and the C-terminal segment (-64.5 residues). 
The Cys- and Glx-residues that form the thiol ester 
site described here are located as residues -472 and 
-469, respectively, from the C-terminus. 
The minor peak of radioactivity in fig.2 (pool 2) 
was found to be caused by a chymotryptic peptide: 
Ser-Phe-Leu-Glu-Asp-Met-Gly-Leu 
The Met-residue of this peptide is known to be 
located 32 residues before the main elastase cleavage 
site in the ‘bait’ region (L. S.-J., T. E. P., S. M., H. 
Jornvall, unpublished). It appears at present that this 
site becomes available to alkylation only after the 
thiol ester haa been cleaved. 
c3: -His-Leu- Ile-Val-Thr-Pro-Ser-Gly-HN-CH-CH-CO-Gly-G~u-NH-CH-CO-Asn-Met- 
LCH2_SZCK&-l*J 
,Ile-Gly- 
6 
azM: -Asn-Leu-teu-Gln-~~~et-Pro-Tyr-Gly-NH-CH-CO-Gly-Glu-NH-CH-CO-Asn-~~et-Val-Leu- -p-- 
kHz-S-C-CHp-CHz' 
J 
Fig.3. A l&residue stretch of sequence [1,2,8] from human ar,-macroglobulin containing the methyl amine reactive Glx-residue 
[ 1,2,8 ], which in the native structure forms a thiol ester bond [ I] with the Cys-residue. The homologous (9 identities in 13 resi- 
dues) sequence [61 from human complement component C3 with the methyl amine reactive Glx residue [ 3,6] in an identical 
thiol ester structure [ 61 is shown for comparison. Identical residues are underlined. 
147 
Volume 123, number 1 FEBS LETTERS January 198 1 
Outdated human plasma was obtained from The 
Blood Bank, Arhus University Hospital, through the 
courtesy of F. Kissmeyer-Nielsen, J. Jorgensen and 
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